IBDEI25E ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36442,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,36442,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,36442,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,36443,0)
 ;;=I05.0^^137^1760^67
 ;;^UTILITY(U,$J,358.3,36443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36443,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,36443,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,36443,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,36444,0)
 ;;=I05.9^^137^1760^68
 ;;^UTILITY(U,$J,358.3,36444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36444,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,36444,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,36444,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,36445,0)
 ;;=I21.3^^137^1760^71
 ;;^UTILITY(U,$J,358.3,36445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36445,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,36445,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,36445,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,36446,0)
 ;;=I44.30^^137^1760^43
 ;;^UTILITY(U,$J,358.3,36446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36446,1,3,0)
 ;;=3^Atrioventricular Block,Unspec
 ;;^UTILITY(U,$J,358.3,36446,1,4,0)
 ;;=4^I44.30
 ;;^UTILITY(U,$J,358.3,36446,2)
 ;;=^5007204
 ;;^UTILITY(U,$J,358.3,36447,0)
 ;;=I50.40^^137^1760^51
 ;;^UTILITY(U,$J,358.3,36447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36447,1,3,0)
 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36447,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,36447,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,36448,0)
 ;;=I50.30^^137^1760^52
 ;;^UTILITY(U,$J,358.3,36448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36448,1,3,0)
 ;;=3^Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36448,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,36448,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,36449,0)
 ;;=I50.20^^137^1760^72
 ;;^UTILITY(U,$J,358.3,36449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36449,1,3,0)
 ;;=3^Systolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36449,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,36449,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,36450,0)
 ;;=I20.0^^137^1760^73
 ;;^UTILITY(U,$J,358.3,36450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36450,1,3,0)
 ;;=3^Unstable Angina
 ;;^UTILITY(U,$J,358.3,36450,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,36450,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,36451,0)
 ;;=M32.12^^137^1760^64
 ;;^UTILITY(U,$J,358.3,36451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36451,1,3,0)
 ;;=3^Pericarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,36451,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,36451,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,36452,0)
 ;;=E87.8^^137^1761^3
 ;;^UTILITY(U,$J,358.3,36452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36452,1,3,0)
 ;;=3^Electrolyte/Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,36452,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,36452,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,36453,0)
 ;;=E11.9^^137^1761^2
 ;;^UTILITY(U,$J,358.3,36453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36453,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,36453,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,36453,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,36454,0)
 ;;=E10.9^^137^1761^1
 ;;^UTILITY(U,$J,358.3,36454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36454,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,36454,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,36454,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,36455,0)
 ;;=Z79.4^^137^1761^4
